Global Targeted RNA Sequencing Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Global Targeted RNA Sequencing Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Table of Contents
1 Study Coverage
1.1 Targeted RNA Sequencing Product Introduction
1.2 Market by Type
1.2.1 Global Targeted RNA Sequencing Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Exome Sequencing
1.2.3 Enrichment Sequencing
1.2.4 Amplicon Sequencing
1.3 Market by Application
1.3.1 Global Targeted RNA Sequencing Market Size Growth Rate by Application (2017 VS 2021 VS 2028)
1.3.2 Research Institutes
1.3.3 Hospitals & Clinics
1.3.4 Biotechnology Company
1.3.5 Diagnostic Lab
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Targeted RNA Sequencing Market Size Estimates and Forecasts
2.2 Targeted RNA Sequencing Market Size by Region: 2022 Versus 2028
2.2.1 Global Targeted RNA Sequencing Revenue by Region: 2017-2022
2.2.2 Global Targeted RNA Sequencing Revenue Forecast by Region (2023-2028)
2.2.3 Global Targeted RNA Sequencing Revenue Market Share by Region (2017-2028)
3 Global Targeted RNA Sequencing by Company
3.1 Global Targeted RNA Sequencing Revenue by Company (2017-2022)
3.2 Global Targeted RNA Sequencing Revenue Share by Company (2017-2022)
3.3 Competitive Landscape
3.3.1 Key Targeted RNA Sequencing Companies around the World: Ranking by Revenue
3.3.2 Global Targeted RNA Sequencing Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.3.3 Global Targeted RNA Sequencing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.4 Global Targeted RNA Sequencing Companies Headquarters & Product Type
3.4.1 Targeted RNA Sequencing Companies Headquarters
3.4.2 Global Targeted RNA Sequencing Companies Product & Service
3.4.3 Date of International Companies Enter into Targeted RNA Sequencing Market
3.5 Global Targeted RNA Sequencing Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Thermo Fisher
4.1.1 Thermo Fisher Corporation Information
4.1.2 Thermo Fisher Description, Business Overview
4.1.3 Thermo Fisher Targeted RNA Sequencing Products Offered
4.1.4 Thermo Fisher Targeted RNA Sequencing Revenue and Gross Margin (2017-2022)
4.1.5 Thermo Fisher Targeted RNA Sequencing Revenue by Product in 2021
4.1.6 Thermo Fisher Targeted RNA Sequencing Revenue by Application in 2021
4.1.7 Thermo Fisher Targeted RNA Sequencing Revenue by Geographic Area in 2021
4.1.8 Thermo Fisher Recent Developments
4.2 Illumina
4.2.1 Illumina Corporation Information
4.2.2 Illumina Description, Business Overview
4.2.3 Illumina Targeted RNA Sequencing Products Offered
4.2.4 Illumina Targeted RNA Sequencing Revenue and Gross Margin (2017-2022)
4.2.5 Illumina Targeted RNA Sequencing Revenue by Product in 2021
4.2.6 Illumina Targeted RNA Sequencing Revenue by Application in 2021
4.2.7 Illumina Targeted RNA Sequencing Revenue by Geographic Area in 2021
4.2.8 Illumina Recent Developments
4.3 Roche Holdings
4.3.1 Roche Holdings Corporation Information
4.3.2 Roche Holdings Description, Business Overview
4.3.3 Roche Holdings Targeted RNA Sequencing Products Offered
4.3.4 Roche Holdings Targeted RNA Sequencing Revenue and Gross Margin (2017-2022)
4.3.5 Roche Holdings Targeted RNA Sequencing Revenue by Product in 2021
4.3.6 Roche Holdings Targeted RNA Sequencing Revenue by Application in 2021
4.3.7 Roche Holdings Targeted RNA Sequencing Revenue by Geographic Area in 2021
4.3.8 Roche Holdings Recent Developments
4.4 BGI
4.4.1 BGI Corporation Information
4.4.2 BGI Description, Business Overview
4.4.3 BGI Targeted RNA Sequencing Products Offered
4.4.4 BGI Targeted RNA Sequencing Revenue and Gross Margin (2017-2022)
4.4.5 BGI Targeted RNA Sequencing Revenue by Product in 2021
4.4.6 BGI Targeted RNA Sequencing Revenue by Application in 2021
4.4.7 BGI Targeted RNA Sequencing Revenue by Geographic Area in 2021
4.4.8 BGI Recent Developments
4.5 Eurofins
4.5.1 Eurofins Corporation Information
4.5.2 Eurofins Description, Business Overview
4.5.3 Eurofins Targeted RNA Sequencing Products Offered
4.5.4 Eurofins Targeted RNA Sequencing Revenue and Gross Margin (2017-2022)
4.5.5 Eurofins Targeted RNA Sequencing Revenue by Product in 2021
4.5.6 Eurofins Targeted RNA Sequencing Revenue by Application in 2021
4.5.7 Eurofins Targeted RNA Sequencing Revenue by Geographic Area in 2021
4.5.8 Eurofins Recent Developments
4.6 LabCorp
4.6.1 LabCorp Corporation Information
4.6.2 LabCorp Description, Business Overview
4.6.3 LabCorp Targeted RNA Sequencing Products Offered
4.6.4 LabCorp Targeted RNA Sequencing Revenue and Gross Margin (2017-2022)
4.6.5 LabCorp Targeted RNA Sequencing Revenue by Product in 2021
4.6.6 LabCorp Targeted RNA Sequencing Revenue by Application in 2021
4.6.7 LabCorp Targeted RNA Sequencing Revenue by Geographic Area in 2021
4.6.8 LabCorp Recent Development
4.7 Berry Genomics
4.7.1 Berry Genomics Corporation Information
4.7.2 Berry Genomics Description, Business Overview
4.7.3 Berry Genomics Targeted RNA Sequencing Products Offered
4.7.4 Berry Genomics Targeted RNA Sequencing Revenue and Gross Margin (2017-2022)
4.7.5 Berry Genomics Targeted RNA Sequencing Revenue by Product in 2021
4.7.6 Berry Genomics Targeted RNA Sequencing Revenue by Application in 2021
4.7.7 Berry Genomics Targeted RNA Sequencing Revenue by Geographic Area in 2021
4.7.8 Berry Genomics Recent Development
4.8 Macrogen
4.8.1 Macrogen Corporation Information
4.8.2 Macrogen Description, Business Overview
4.8.3 Macrogen Targeted RNA Sequencing Products Offered
4.8.4 Macrogen Targeted RNA Sequencing Revenue and Gross Margin (2017-2022)
4.8.5 Macrogen Targeted RNA Sequencing Revenue by Product in 2021
4.8.6 Macrogen Targeted RNA Sequencing Revenue by Application in 2021
4.8.7 Macrogen Targeted RNA Sequencing Revenue by Geographic Area in 2021
4.8.8 Macrogen Recent Development
4.9 GENEWIZ
4.9.1 GENEWIZ Corporation Information
4.9.2 GENEWIZ Description, Business Overview
4.9.3 GENEWIZ Targeted RNA Sequencing Products Offered
4.9.4 GENEWIZ Targeted RNA Sequencing Revenue and Gross Margin (2017-2022)
4.9.5 GENEWIZ Targeted RNA Sequencing Revenue by Product in 2021
4.9.6 GENEWIZ Targeted RNA Sequencing Revenue by Application in 2021
4.9.7 GENEWIZ Targeted RNA Sequencing Revenue by Geographic Area in 2021
4.9.8 GENEWIZ Recent Development
5 Breakdown Data by Type
5.1 Global Targeted RNA Sequencing Revenue by Type (2017-2022)
5.2 Global Targeted RNA Sequencing Revenue Forecast by Type (2023-2028)
5.3 Targeted RNA Sequencing Revenue Marke Share by Type (2017-2028)
6 Breakdown Data by Application
6.1 Global Targeted RNA Sequencing Revenue by Application (2017-2022)
6.2 Global Targeted RNA Sequencing Revenue Forecast by Application (2023-2028)
6.3 Targeted RNA Sequencing Revenue Market Share by Application (2017-2028)
7 North America
7.1 North America Targeted RNA Sequencing Market Size YoY Growth 2017-2028
7.2 North America Targeted RNA Sequencing Market Facts & Figures by Country (2017-2028)
7.3 North America Targeted RNA Sequencing Revenue by Type (2017-2022)
7.4 North America Targeted RNA Sequencing Revenue by Application (2017-2022)
8 Asia-Pacific
8.1 Asia-Pacific Targeted RNA Sequencing Market Size YoY Growth 2017-2028
8.2 Asia-Pacific Targeted RNA Sequencing Market Facts & Figures by Region (2017-2028)
8.3 Asia-Pacific Targeted RNA Sequencing Revenue by Type (2017-2022)
8.4 Asia-Pacific Targeted RNA Sequencing Revenue by Application (2017-2022)
9 Europe
9.1 Europe Targeted RNA Sequencing Market Size YoY Growth 2017-2028
9.2 Europe Targeted RNA Sequencing Market Facts & Figures by Country (2017-2028)
9.3 Europe Targeted RNA Sequencing Revenue by Type (2017-2022)
9.4 Europe Targeted RNA Sequencing Revenue by Application (2017-2022)
10 Latin America
10.1 Latin America Targeted RNA Sequencing Market Size YoY Growth 2017-2028
10.2 Latin America Targeted RNA Sequencing Market Facts & Figures by Country (2017-2028)
10.3 Latin America Targeted RNA Sequencing Revenue by Type (2017-2022)
10.4 Latin America Targeted RNA Sequencing Revenue by Application (2017-2022)
11 Middle East and Africa
11.1 Middle East and Africa Targeted RNA Sequencing Market Size YoY Growth 2017-2028
11.2 Middle East and Africa Targeted RNA Sequencing Market Facts & Figures by Country (2017-2028)
11.3 Middle East and Africa Targeted RNA Sequencing Revenue by Type (2017-2022)
11.4 Middle East and Africa Targeted RNA Sequencing Revenue by Application (2017-2022)
12 Supply Chain and Sales Channel Analysis
12.1 Targeted RNA Sequencing Supply Chain Analysis
12.2 Targeted RNA Sequencing Key Raw Materials and Upstream Suppliers
12.3 Targeted RNA Sequencing Clients Analysis
12.4 Targeted RNA Sequencing Sales Channel and Sales Model Analysis
12.4.1 Targeted RNA Sequencing Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Targeted RNA Sequencing Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Targeted RNA Sequencing Distributors
13 Market Dynamics
13.1 Targeted RNA Sequencing Industry Trends
13.2 Targeted RNA Sequencing Market Drivers
13.3 Targeted RNA Sequencing Market Challenges
13.4 Targeted RNA Sequencing Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Targeted RNA Sequencing Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Major Companies of Exome Sequencing
Table 3. Major Companies of Enrichment Sequencing
Table 4. Major Companies of Amplicon Sequencing
Table 5. Global Targeted RNA Sequencing Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Targeted RNA Sequencing Market Size by Region (US$ Million): 2022 VS 2028
Table 7. Global Targeted RNA Sequencing Revenue by Region (2017-2022) & (US$ Million)
Table 8. Global Targeted RNA Sequencing Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 9. Targeted RNA Sequencing Revenue by Company (2017-2022) & (US$ Million)
Table 10. Targeted RNA Sequencing Revenue Share by Company (2017-2022)
Table 11. Ranking of Global Top Targeted RNA Sequencing Players by Revenue (US$ Million) in 2021
Table 12. Global Targeted RNA Sequencing Companies Market Concentration Ratio (CR5 and HHI) & (2017-2022)
Table 13. Global Targeted RNA Sequencing by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Targeted RNA Sequencing as of 2021)
Table 14. Global Targeted RNA Sequencing Companies Headquarters
Table 15. Global Targeted RNA Sequencing Companies Product & Service
Table 16. Date of International Companies Enter into Targeted RNA Sequencing Market
Table 17. Global Targeted RNA Sequencing Mergers & Acquisitions, Expansion Plans
Table 18. Thermo Fisher Corporation Information
Table 19. Thermo Fisher Description and Business Overview
Table 20. Thermo Fisher Targeted RNA Sequencing Revenue (US$ Million) and Gross Margin (2017-2022)
Table 21. Thermo Fisher Targeted RNA Sequencing Product
Table 22. Thermo Fisher Targeted RNA Sequencing Revenue Proportion of Targeted RNA Sequencing by Product in 2021
Table 23. Thermo Fisher Targeted RNA Sequencing Revenue Proportion of Targeted RNA Sequencing by Application in 2021
Table 24. Thermo Fisher Targeted RNA Sequencing Revenue Proportion of Targeted RNA Sequencing by Geographic Area in 2021
Table 25. Thermo Fisher Recent Development
Table 26. Illumina Corporation Information
Table 27. Illumina Description and Business Overview
Table 28. Illumina Targeted RNA Sequencing Revenue (US$ Million) and Gross Margin (2017-2022)
Table 29. Illumina Targeted RNA Sequencing Product
Table 30. Illumina Targeted RNA Sequencing Revenue Proportion of Targeted RNA Sequencing by Product in 2021
Table 31. Illumina Targeted RNA Sequencing Revenue Proportion of Targeted RNA Sequencing by Application in 2021
Table 32. Illumina Targeted RNA Sequencing Revenue Proportion of Targeted RNA Sequencing by Geographic Area in 2021
Table 33. Illumina Recent Development
Table 34. Roche Holdings Corporation Information
Table 35. Roche Holdings Description and Business Overview
Table 36. Roche Holdings Targeted RNA Sequencing Revenue (US$ Million) and Gross Margin (2017-2022)
Table 37. Roche Holdings Targeted RNA Sequencing Product
Table 38. Roche Holdings Targeted RNA Sequencing Revenue Proportion of Targeted RNA Sequencing by Product in 2021
Table 39. Roche Holdings Targeted RNA Sequencing Revenue Proportion of Targeted RNA Sequencing by Application in 2021
Table 40. Roche Holdings Targeted RNA Sequencing Revenue Proportion of Targeted RNA Sequencing by Geographic Area in 2021
Table 41. Roche Holdings Recent Development
Table 42. BGI Corporation Information
Table 43. BGI Description and Business Overview
Table 44. BGI Targeted RNA Sequencing Revenue (US$ Million) and Gross Margin (2017-2022)
Table 45. BGI Targeted RNA Sequencing Product
Table 46. BGI Targeted RNA Sequencing Revenue Proportion of Targeted RNA Sequencing by Product in 2021
Table 47. BGI Targeted RNA Sequencing Revenue Proportion of Targeted RNA Sequencing by Application in 2021
Table 48. BGI Targeted RNA Sequencing Revenue Proportion of Targeted RNA Sequencing by Geographic Area in 2021
Table 49. BGI Recent Development
Table 50. Eurofins Corporation Information
Table 51. Eurofins Description and Business Overview
Table 52. Eurofins Targeted RNA Sequencing Revenue (US$ Million) and Gross Margin (2017-2022)
Table 53. Eurofins Targeted RNA Sequencing Product
Table 54. Eurofins Targeted RNA Sequencing Revenue Proportion of Targeted RNA Sequencing by Product in 2021
Table 55. Eurofins Targeted RNA Sequencing Revenue Proportion of Targeted RNA Sequencing by Application in 2021
Table 56. Eurofins Targeted RNA Sequencing Revenue Proportion of Targeted RNA Sequencing by Geographic Area in 2021
Table 57. Eurofins Recent Development
Table 58. LabCorp Corporation Information
Table 59. LabCorp Description and Business Overview
Table 60. LabCorp Targeted RNA Sequencing Revenue (US$ Million) and Gross Margin (2017-2022)
Table 61. LabCorp Targeted RNA Sequencing Product
Table 62. LabCorp Targeted RNA Sequencing Revenue Proportion of Targeted RNA Sequencing by Product in 2021
Table 63. LabCorp Targeted RNA Sequencing Revenue Proportion of Targeted RNA Sequencing by Application in 2021
Table 64. LabCorp Targeted RNA Sequencing Revenue Proportion of Targeted RNA Sequencing by Geographic Area in 2021
Table 65. Berry Genomics Corporation Information
Table 66. Berry Genomics Description and Business Overview
Table 67. Berry Genomics Targeted RNA Sequencing Revenue (US$ Million) and Gross Margin (2017-2022)
Table 68. Berry Genomics Targeted RNA Sequencing Product
Table 69. Berry Genomics Targeted RNA Sequencing Revenue Proportion of Targeted RNA Sequencing by Product in 2021
Table 70. Berry Genomics Targeted RNA Sequencing Revenue Proportion of Targeted RNA Sequencing by Application in 2021
Table 71. Berry Genomics Targeted RNA Sequencing Revenue Proportion of Targeted RNA Sequencing by Geographic Area in 2021
Table 72. Macrogen Corporation Information
Table 73. Macrogen Description and Business Overview
Table 74. Macrogen Targeted RNA Sequencing Revenue (US$ Million) and Gross Margin (2017-2022)
Table 75. Macrogen Targeted RNA Sequencing Product
Table 76. Macrogen Targeted RNA Sequencing Revenue Proportion of Targeted RNA Sequencing by Product in 2021
Table 77. Macrogen Targeted RNA Sequencing Revenue Proportion of Targeted RNA Sequencing by Application in 2021
Table 78. Macrogen Targeted RNA Sequencing Revenue Proportion of Targeted RNA Sequencing by Geographic Area in 2021
Table 79. GENEWIZ Corporation Information
Table 80. GENEWIZ Description and Business Overview
Table 81. GENEWIZ Targeted RNA Sequencing Revenue (US$ Million) and Gross Margin (2017-2022)
Table 82. GENEWIZ Targeted RNA Sequencing Product
Table 83. GENEWIZ Targeted RNA Sequencing Revenue Proportion of Targeted RNA Sequencing by Product in 2021
Table 84. GENEWIZ Targeted RNA Sequencing Revenue Proportion of Targeted RNA Sequencing by Application in 2021
Table 85. GENEWIZ Targeted RNA Sequencing Revenue Proportion of Targeted RNA Sequencing by Geographic Area in 2021
Table 86. Global Targeted RNA Sequencing Revenue by Type (2017-2022) & (US$ Million)
Table 87. Global Targeted RNA Sequencing Revenue by Application (2017-2022) & (US$ Million)
Table 88. Global Targeted RNA Sequencing Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 89. North America Targeted RNA Sequencing Revenue by Country (2017-2022) & (US$ Million)
Table 90. North America Targeted RNA Sequencing Revenue by Country (2023-2028) & (US$ Million)
Table 91. North America Targeted RNA Sequencing Revenue by Type (2017-2022) & (US$ Million)
Table 92. North America Targeted RNA Sequencing Revenue by Application (2017-2022) & (US$ Million)
Table 93. Asia-Pacific Targeted RNA Sequencing Revenue by Region (2017-2028) & (US$ Million)
Table 94. Asia-Pacific Targeted RNA Sequencing Revenue by Region (2023-2028) & (US$ Million)
Table 95. Asia-Pacific Targeted RNA Sequencing Revenue by Type (2017-2022) & (US$ Million)
Table 96. Asia-Pacific Targeted RNA Sequencing Revenue by Application (2017-2022) & (US$ Million)
Table 97. Europe Targeted RNA Sequencing Revenue by Country (2017-2022) & (US$ Million)
Table 98. Europe Targeted RNA Sequencing Revenue by Country (2023-2028) & (US$ Million)
Table 99. Europe Targeted RNA Sequencing Revenue by Type (2017-2022) & (US$ Million)
Table 100. Europe Targeted RNA Sequencing Revenue by Application (2017-2022) & (US$ Million)
Table 101. Latin America Targeted RNA Sequencing Revenue by Country (2017-2022) & (US$ Million)
Table 102. Latin America Targeted RNA Sequencing Revenue by Country (2023-2028) & (US$ Million)
Table 103. Latin America Targeted RNA Sequencing Revenue by Type (2017-2022) & (US$ Million)
Table 104. Latin America Targeted RNA Sequencing Revenue by Application (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Targeted RNA Sequencing Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Targeted RNA Sequencing Revenue by Country (2023-2028) & (US$ Million)
Table 107. Middle East and Africa Targeted RNA Sequencing Revenue by Type (2017-2022) & (US$ Million)
Table 108. Middle East and Africa Targeted RNA Sequencing Revenue by Application (2017-2022) & (US$ Million)
Table 109. Targeted RNA Sequencing Key Raw Materials, Industry Status and Trend
Table 110. Targeted RNA Sequencing Key Raw Materials and Upstream Suppliers
Table 111. Targeted RNA Sequencing Clients Status and Trend
Table 112. Targeted RNA Sequencing Typical Clients
Table 113. Targeted RNA Sequencing Distributors
Table 114. Targeted RNA Sequencing Market Trends
Table 115. Targeted RNA Sequencing Market Drivers
Table 116. Targeted RNA Sequencing Market Challenges
Table 117. Targeted RNA Sequencing Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Targeted RNA Sequencing Product Picture
Figure 2. Global Targeted RNA Sequencing Revenue Market Share by Type in 2021 & 2028
Figure 3. Exome Sequencing Product Picture
Figure 4. Enrichment Sequencing Product Picture
Figure 5. Amplicon Sequencing Product Picture
Figure 6. Global Targeted RNA Sequencing Revenue Market Share by Application in 2021 & 2028
Figure 7. Research Institutes
Figure 8. Hospitals & Clinics
Figure 9. Biotechnology Company
Figure 10. Diagnostic Lab
Figure 11. Targeted RNA Sequencing Report Years Considered
Figure 12. Global Targeted RNA Sequencing Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Targeted RNA Sequencing Market Size 2017-2028 (US$ Million)
Figure 14. Global Targeted RNA Sequencing Market Size Market Share by Region: 2022 Versus 2028
Figure 15. Global Targeted RNA Sequencing Revenue Market Share by Region (2017-2028)
Figure 16. Targeted RNA Sequencing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 17. Global Targeted RNA Sequencing Revenue Market Share Forecast by Type (2017-2028)
Figure 18. Global Targeted RNA Sequencing Revenue Market Share Forecast by Application (2017-2028)
Figure 19. North America Targeted RNA Sequencing Revenue 2017-2028 (US$ Million)
Figure 20. North America Targeted RNA Sequencing Revenue Market Share by Type (2017-2022)
Figure 21. North America Targeted RNA Sequencing Revenue Market Share by Application (2017-2022)
Figure 22. Asia-Pacific Targeted RNA Sequencing Revenue 2017-2028 (US$ Million)
Figure 23. Asia-Pacific Targeted RNA Sequencing Revenue Market Share by Region (2017-2028)
Figure 24. Asia-Pacific Targeted RNA Sequencing Revenue Market Share by Type (2017-2022)
Figure 25. Asia-Pacific Targeted RNA Sequencing Revenue Market Share by Application (2017-2022)
Figure 26. Europe Targeted RNA Sequencing Revenue Growth Rate 2017-2028 (US$ Million)
Figure 27. Europe Targeted RNA Sequencing Revenue Market Share by Country (2017-2028)
Figure 28. Europe Targeted RNA Sequencing Revenue Market Share by Type (2017-2022)
Figure 29. Europe Targeted RNA Sequencing Revenue Market Share by Application (2017-2022)
Figure 30. Latin America Targeted RNA Sequencing Revenue Growth Rate 2017-2028 (US$ Million)
Figure 31. Latin America Targeted RNA Sequencing Revenue Market Share by Country (2017-2022)
Figure 32. Latin America Targeted RNA Sequencing Revenue Market Share by Type (2017-2022)
Figure 33. Latin America Targeted RNA Sequencing Revenue Market Share by Application (2017-2022)
Figure 34. Middle East and Africa Targeted RNA Sequencing Revenue Growth Rate 2017-2028 (US$ Million)
Figure 35. Middle East and Africa Targeted RNA Sequencing Revenue Market Share by Country (2017-2028)
Figure 36. Middle East and Africa Targeted RNA Sequencing Revenue Market Share by Type (2017-2022)
Figure 37. Middle East and Africa Targeted RNA Sequencing Revenue Market Share by Application (2017-2022)
Figure 38. Targeted RNA Sequencing Supply Chain (Upstream and Downstream Market)
Figure 39. Global Production Market Share of Targeted RNA Sequencing Raw Materials by Region in 2021
Figure 40. Targeted RNA Sequencing Distribution Channels
Figure 41. Global Targeted RNA Sequencing Percentage 2017-2028: Indirect Sales VS Direct Sales
Figure 42. Global Targeted RNA Sequencing Percentage 2017-2028: Online Sales VS Offline Sales
Figure 43. Bottom-up and Top-down Approaches for This Report
Figure 44. Data Triangulation
Figure 45. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Targeted RNA Sequencing Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 71

Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or amplicon-based approaches, both of which enable gene expression analysis in a focused set of genes of interest, with enrichment assays also providing The ability to detect both known and novel gene fusion partners in many sample types. In The report, we ......

Global Targeted RNA Sequencing Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 87

According to our LPI (LP Information) latest study, the global Targeted RNA Sequencing market size was valued at US$ 1761.4 million in 2023. With growing demand in downstream market, the Targeted RNA Sequencing is forecast to a readjusted size of US$ 7649.2 million by 2030 with a CAGR of 23.3% during review period. The research report highlights the growth potential of the global Targeted RNA Sequencing market. Targeted RNA Sequencing are expected to show stable growth in the future mark......

Global Targeted RNA Sequencing Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 94

According to our (Global Info Research) latest study, the global Targeted RNA Sequencing market size was valued at USD 1852.7 million in 2023 and is forecast to a readjusted size of USD 7255.4 million by 2030 with a CAGR of 21.5% during review period. Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or ......

Global Antisense and RNAi Therapeutics Market Research Report 2023, Forecast to 2028

Published: 26-Dec-2023        Price: US 2680 Onwards        Pages: 133

Antisense therapy means the selective, sequence-specific inhibition of gene expression by single-stranded DNA oligonucleotides. In contrast, RNA interference (RNAi) is triggered by double-stranded RNA (dsRNA) and causes sequence-specific mRNA degradation of single-stranded target RNAs in response to dsRNA. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (millio......

Global Antisense and RNAi Therapeutics Professional Survey Report 2023, Forecast to 2028

Published: 26-Dec-2023        Price: US 3280 Onwards        Pages: 101

Antisense therapy means the selective, sequence-specific inhibition of gene expression by single-stranded DNA oligonucleotides. In contrast, RNA interference (RNAi) is triggered by double-stranded RNA (dsRNA) and causes sequence-specific mRNA degradation of single-stranded target RNAs in response to dsRNA. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (millio......

Global Targeted RNA Sequencing Market Research Report 2023, Forecast to 2028

Published: 13-Nov-2023        Price: US 2680 Onwards        Pages: 137

Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest.  Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product ......

Global Targeted RNA Sequencing Professional Survey Report 2023, Forecast to 2028

Published: 13-Nov-2023        Price: US 3280 Onwards        Pages: 100

Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest.  Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product ......

Global RNAi for Therapeutic Market Status and Outlook 2023-2028

Published: 08-Nov-2023        Price: US 3160 Onwards        Pages: 106

RNAi is a fundamental cellular mechanism for silencing gene expression that can be harnessed for the development of new drugs Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product ......

Global RNAi for Therapeutic Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 24-Oct-2023        Price: US 3380 Onwards        Pages: 104

Market Overview of Global RNAi for Therapeutic market: According to our latest research, the global RNAi for Therapeutic market looks promising in the next 5 years. As of 2022, the global RNAi for Therapeutic market was estimated at USD 260.55 million, and it's anticipated to reach USD 3633.33 million in 2028, with a CAGR of 55.14% during the forecast years. RNA interference (RNAi) is a collection of small RNA directed mechanisms that result in sequence specific inhibition of......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs